Literature DB >> 30764010

Transthyretin: roles in the nervous system beyond thyroxine and retinol transport.

Sandra Marisa Oliveira1, Isabel Cardoso1,2, Maria João Saraiva1,3.   

Abstract

Transthyretin (TTR) is a plasma- and cerebrospinal fluid-circulating protein. Besides the primordially attributed systemic role as a transporter molecule of thyroxine (T4) and retinol (through the binding to retinol-binding protein [RBP]), TTR has been recognized as a protein with important functions in several aspects of the nervous system physiology. TTR has been shown to play an important role in behavior, cognition, amidated neuropeptide processing and nerve regeneration. Furthermore, it has been proposed that TTR is neuroprotective in Alzheimer's disease and cerebral ischemia. Mutations in TTR are a well-known cause of familial amyloidotic polyneuropathy, an autosomal dominant neurodegenerative disorder characterized by systemic deposition of TTR amyloid fibrils, particularly in the peripheral nervous system. The purpose of this review is to highlight the roles of TTR in the nervous system, beyond its systemic role as a transporter molecule of T4 and RBP-retinol.

Entities:  

Keywords:  Alzheimer’s disease; familial amyloidotic polyneuropathy; ischemia; nervous system; neuroprotection; retinol; thyroxine; transport; transthyretin

Year:  2012        PMID: 30764010     DOI: 10.1586/eem.12.2

Source DB:  PubMed          Journal:  Expert Rev Endocrinol Metab        ISSN: 1744-6651


  5 in total

1.  In vivo gene editing works in humans: Results of a phase 1 clinical trial for TTR amyloidosis.

Authors:  Ana Rita Batista; Terence R Flotte
Journal:  Mol Ther       Date:  2021-08-24       Impact factor: 12.910

2.  Divergence Entropy-Based Evaluation of Hydrophobic Core in Aggressive and Resistant Forms of Transthyretin.

Authors:  Mateusz Banach; Katarzyna Stapor; Piotr Fabian; Leszek Konieczny; Irena Roterman
Journal:  Entropy (Basel)       Date:  2021-04-13       Impact factor: 2.524

3.  Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD.

Authors:  Xabier Rios; Vanessa Gómez-Vallejo; Abraham Martín; Unai Cossío; Miguel Ángel Morcillo; Mobina Alemi; Isabel Cardoso; Jordi Quintana; Jesús Jiménez-Barbero; Ellen Y Cotrina; Gregorio Valencia; Gemma Arsequell; Jordi Llop
Journal:  Sci Rep       Date:  2019-09-20       Impact factor: 4.379

Review 4.  Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer's Disease?

Authors:  Federica Saponaro; Jin Hae Kim; Grazia Chiellini
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

5.  Deficiency of N-glycanase 1 perturbs neurogenesis and cerebral development modeled by human organoids.

Authors:  Victor J T Lin; Jiangnan Hu; Ashwini Zolekar; Max R Salick; Parul Mittal; Jordan T Bird; Peter Hoffmann; Ajamete Kaykas; Stephanie D Byrum; Yu-Chieh Wang
Journal:  Cell Death Dis       Date:  2022-03-24       Impact factor: 9.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.